
Salicylic Acid (16.7% w/v) + Lactic Acid (16.7% w/v)
Active composition
+1 more active ingredient
Salicylic Acid promotes keratinocyte turnover and reduces inflammation, leading to improved skin texture and reduced acne lesions.
Lactic Acid increases the turnover rate of epithelial cells, facilitating exfoliation and hydration by breaking down keratin, thus enhancing skin smoothness and moisture retention.
Medical applications
Epiwart Solution is a topical medication formulated with Salicylic Acid (16.7% w/v) and Lactic Acid (16.7% w/v), indicated for the treatment of common warts and other hyperkeratotic skin lesions. Salicylic Acid acts as a keratolytic agent, promoting the gradual exfoliation and removal of the thickened, keratinized skin layers characteristic of warts. Concurrently, Lactic Acid serves to enhance the keratolytic effect by softening the skin and improving the penetration of Salicylic Acid into the lesion. The combined action facilitates the breakdown of wart tissue, leading to lesion resolution over a course of treatment. Epiwart Solution is applied directly to the affected area once or twice daily, following proper skin cleansing and drying. Patients should avoid contact with healthy skin and mucous membranes to minimize irritation. Common adverse effects may include mild local irritation, redness, or peeling at the application site. Use is contraindicated in individuals with hypersensitivity to salicylates or lactic acid, and caution is advised in patients with diabetes or poor peripheral circulation. Epiwart Solution offers an effective, non-invasive therapeutic option for wart management when used as directed under medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Epiwart Solution during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Epiwart Solution during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Epiwart Solution

Salicylic Acid (16.7% w/v) + Lactic Acid (16.7% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Salicylic Acid promotes keratinocyte turnover and reduces inflammation, leading to improved skin texture and reduced acne lesions.
Lactic Acid increases the turnover rate of epithelial cells, facilitating exfoliation and hydration by breaking down keratin, thus enhancing skin smoothness and moisture retention.
Medical applications
Epiwart Solution is a topical medication formulated with Salicylic Acid (16.7% w/v) and Lactic Acid (16.7% w/v), indicated for the treatment of common warts and other hyperkeratotic skin lesions. Salicylic Acid acts as a keratolytic agent, promoting the gradual exfoliation and removal of the thickened, keratinized skin layers characteristic of warts. Concurrently, Lactic Acid serves to enhance the keratolytic effect by softening the skin and improving the penetration of Salicylic Acid into the lesion. The combined action facilitates the breakdown of wart tissue, leading to lesion resolution over a course of treatment. Epiwart Solution is applied directly to the affected area once or twice daily, following proper skin cleansing and drying. Patients should avoid contact with healthy skin and mucous membranes to minimize irritation. Common adverse effects may include mild local irritation, redness, or peeling at the application site. Use is contraindicated in individuals with hypersensitivity to salicylates or lactic acid, and caution is advised in patients with diabetes or poor peripheral circulation. Epiwart Solution offers an effective, non-invasive therapeutic option for wart management when used as directed under medical supervision.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Epiwart Solution during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Epiwart Solution during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
No interaction found/established
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Epiwart Solution















